Stress-activated protein kinase-2 p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis

被引:272
作者
Cuenda, A [1 ]
Cohen, P [1 ]
机构
[1] Univ Dundee, Dept Biochem, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland
关键词
D O I
10.1074/jbc.274.7.4341
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The differentiation of C2C12 myoblasts to myotubes was found to be accompanied by a strong activation of p70 S6 kinase and the mitogen-activated protein kinase (MAPK) family member SAPK2/p38, without significant activation of p42 MAPK and only slight activation of SAPK1/JNK and protein kinase B alpha. Consistent with these findings, SE 203580 (a specific inhibitor of SAPK2/p38) or rapamycin (which blocks the activation of p70 S6 kinase) prevented the formation of multinucleated myotubes, as well as the expression of muscle-specific proteins that included SAPK3 (another MAPK family member). PD 098059 (which prevents the activation of p42 MAPK) had no effect on myotube formation. Surprisingly, the slow activation of p70 S6 kinase during differentiation was not only prevented by rapamycin but also by SE 203580, and the activation of MAPKAP kinase-2 (an in vivo substrate of SAPK2/p38) was not only prevented by SE 203580 but also by rapamycin. In contrast, the acute activation of p70 S6 kinase in C2C12 myoblasts induced by phorbol esters was unaffected by SE 203580 and the acute activation of MAPKAP kinase-g induced by anisomycin was unaffected by rapamycin, These results show for the first time that SAPK2/p38 plays an essential role in C2C12 cell differentiation.
引用
收藏
页码:4341 / 4346
页数:6
相关论文
共 36 条
  • [1] ALEMA S, 1994, SEMIN CANCER BIOL, V5, P147
  • [2] ALESSI DR, 1995, METHOD ENZYMOL, V255, P279
  • [3] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [4] PHOSPHOTYROSINE RESIDUES IN THE NERVE-GROWTH-FACTOR RECEPTOR (TRK-A) - THEIR ROLE IN THE ACTIVATION OF INOSITOLPHOSPHOLIPID METABOLISM AND PROTEIN-KINASE CASCADES IN PHEOCHROMOCYTOMA (PC12) CELLS
    BAXTER, RM
    COHEN, P
    OBERMEIER, A
    ULLRICH, A
    DOWNES, CP
    DOZA, YN
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 234 (01): : 84 - 91
  • [5] Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases
    Bennett, AM
    Tonks, NK
    [J]. SCIENCE, 1997, 278 (5341) : 1288 - 1291
  • [6] A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX
    BROWN, EJ
    ALBERS, MW
    SHIN, TB
    ICHIKAWA, K
    KEITH, CT
    LANE, WS
    SCHREIBER, SL
    [J]. NATURE, 1994, 369 (6483) : 756 - 758
  • [7] Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin
    Brunn, GJ
    Hudson, CC
    Sekulic, A
    Williams, JM
    Hosoi, H
    Houghton, PJ
    Lawrence, JC
    Abraham, RT
    [J]. SCIENCE, 1997, 277 (5322) : 99 - 101
  • [8] Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002
    Brunn, GJ
    Williams, J
    Sabers, C
    Wiederrecht, G
    Lawrence, JC
    Abraham, RT
    [J]. EMBO JOURNAL, 1996, 15 (19) : 5256 - 5267
  • [9] INTERLEUKIN-2 STIMULATION OF P70 S6 KINASE-ACTIVITY IS INHIBITED BY THE IMMUNOSUPPRESSANT RAPAMYCIN
    CALVO, V
    CREWS, CM
    VIK, TA
    BIERER, BE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) : 7571 - 7575